Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 16627542.
- Also identified by PMC identifier 1798254.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Understanding of the natural history and basic biology of hepatitis B virus (HBV) has increased greatly in recent years. In view of this, the following are reviewed here: (a) recent advances in HBV biology pertinent to the rheumatic disease population; (b) the risks of HBV reactivation in patients with rheumatic disease undergoing immunosuppression; and (c) potential strategies to manage these risks.
Medical subject headings
- Hepatitis B
- Hepatitis B virus
- Immunocompromised Host
- Rheumatic Diseases
- Virus Activation